Trials / Terminated
TerminatedNCT02204228
TITAN™ Reverse Shoulder System
A Post-market Clinical Follow-up Study of the TITAN™ Reverse Shoulder System Used in Primary or Revision Total Shoulder Arthroplasty
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 151 (actual)
- Sponsor
- Smith & Nephew, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The Integra® TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct. When used under the conditions and purposes intended the TRS will relieve pain and restore some functional joint motion to the affected shoulder. The purpose of this study is to assess the short, mid and long term outcomes of the TITAN™ Reverse Shoulder System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TITAN™ Reverse Shoulder System (TRS) | All patients will be operated on with the TITAN™ Reverse Shoulder System (TRS). |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2023-12-14
- Completion
- 2023-12-14
- First posted
- 2014-07-30
- Last updated
- 2026-03-13
Locations
10 sites across 4 countries: United States, France, Spain, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02204228. Inclusion in this directory is not an endorsement.